To be used as a topically applied ocular beta blocker a
drug should have the following properties except:
A. Strong local anaesthetic activity
B. High lipophilicity
C. High ocular capture
D. Low systemic activity
drug should have the following properties except:
A. Strong local anaesthetic activity
B. High lipophilicity
C. High ocular capture
D. Low systemic activity